Overall, 4 percent of African American patients and 34 percent of white patients were HPV positive. Cullen said the survival difference was entirely due to HPV status, as survival rates were similar among HPV-negative patients.
Scott Lippman, M.D., chair of the Department of Clinical Cancer Prevention at the University of Texas M. D. Anderson Cancer Center and editor-in-chief of Cancer Prevention Research called the study "practice changing."